Clinics And Research In Hepatology And Gastroenterology

SCIE

國際簡稱：CLIN RES HEPATOL GAS 參考譯名：肝病學和胃腸病學的診所和研究

主要研究方向：GASTROENTEROLOGY & HEPATOLOGY 非預警期刊審稿周期：偏慢,4-8周

《肝病學和胃腸病學的診所和研究》(Clinics And Research In Hepatology And Gastroenterology)是一本由Elsevier Masson出版的以GASTROENTEROLOGY & HEPATOLOGY為研究特色的國際期刊，發表該領域相關的原創研究文章、評論文章和綜述文章，及時報道該領域相關理論、實踐和應用學科的最新發現，旨在促進該學科領域科學信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預警名單。

4區中科院分區
Q2 JCR分區
111 年發文量
2.6 IF影響因子
未開放 是否OA
51 H-index
2011 創刊年份
6 issues/year 出版周期
English 出版語言

Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).

Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.

[ 查看全部 ]

投稿咨詢加急咨詢

Clinics And Research In Hepatology And Gastroenterology期刊信息

ISSN：2210-7401
出版語言：English
是否OA：未開放
E-ISSN：2210-741X
出版地區：FRANCE
是否預警：否
出版商：Elsevier Masson
出版周期：6 issues/year
創刊時間：2011
開源占比：0.105
Gold OA文章占比：27.16%
OA被引用占比：0.0018...
出版國人文章占比：0.23
出版撤稿占比：0
研究類文章占比：73.87%

Clinics And Research In Hepatology And Gastroenterology CiteScore評價數據（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數

4.3

0.676

0.616

學科類別	分區	排名	百分位
大類：Medicine 小類：Gastroenterology	Q2	77 / 167	54%

名詞解釋：CiteScore 是衡量期刊所發表文獻的平均受引用次數，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據是期刊最近4年（含計算年度）的被引次數除以該期刊近四年發表的文獻數。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發表的文件的引用數量÷2019-2022年發布的文獻數量注：文獻類型包括：文章、評論、會議論文、書籍章節和數據論文。

Clinics And Research In Hepatology And Gastroenterology中科院評價數據

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院 2021年12月基礎版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	3區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學科		小類學科
否	否	醫學	4區	GASTROENTEROLOGY & HEPATOLOGY 胃腸肝病學	4區

Clinics And Research In Hepatology And Gastroenterology JCR評價數據（2023-2024年最新版）

按JIF指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	67 / 143	53.5%

按JCI指標學科分區	收錄子集	分區	排名	百分位
學科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	70 / 143	51.4%

Clinics And Research In Hepatology And Gastroenterology歷年數據統計

影響因子

中科院分區

Clinics And Research In Hepatology And Gastroenterology中國學者發文選摘

1、Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial
Author: Liu, Dan-Ni; Wang, Qiu-Yan; Li, Pei -Yuan; Wu, Dong-Han; Pan, Jing; Chen, Zheng-Yi; Li, Yan-Qiang; Han, Xiang-Yang; Lan, Cheng; Tang, Jing; Tan, Yan; Mo, Cui-Yi; Yang, Wei-Zhong; Han, Jun-Ling; Huang, Xiao-Xi

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 5, pp. -. DOI: 10.1016/j.clinre.2023.102125
2、Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis
Author: Du, Fei; Zhang, Lingkai; Zhang, Yongxuan; Fan, Haining; Ren, Li

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102069
3、Metabolic-associated fatty liver disease and the risk of cardiovascular disease
Author: Zhang, Pengwei; Dong, Xianhui; Zhang, Wei; Wang, Shiyin; Chen, Chen; Tang, Jiake; You, Yao; Hu, Siqi; Zhang, Shenghui; Wang, Chunyi; Wen, Wen; Zhou, Mengyun; Tan, Tao; Qi, Guanming; Li, Li; Wang, Mingwei

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102063
4、The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy
Author: Wang, Manzhou; Sun, Limin; Han, Xinwei; Ren, Jianzhuang; Li, Hao; Wang, Wenhui; Xu, Wenze; Liang, Chao; Duan, Xuhua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102060
5、Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019
Author: Tian, Hongzhan; Zhang, Kexin; Hui, Zongguang; Ren, Fangbing; Ma, Yanhui; Han, Fang; Sun, Xiaodong; Kan, Chengxia; Hou, Ningning

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102068
6、LncRNA ZFAS1 ameliorates injury led by non- alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
Author: Liu, Lu; Sun, Sen; Li, Xiaohua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102067
7、Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors
Author: Zhang, Lijie; Zhang, Xin; Li, Qing; Makamure, Joyman; Liu, Ziyi; Zhao, Dan; Li, Xin; Shi, Heshui; Zheng, Chuansheng; Liu, Fengyong; Liang, Bin

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102071
8、T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease
Author: Xiong, Wanyuan; Qian, Zibing; Mao, Xiaorong; Li, Junfeng

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102070